Skip to Main Content

Advertisement

Skip Nav Destination

Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma

Blood (2018) 132 (24): 2546–2554.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement